Loncar Cancer Immunotherapy ETF (CNCR) dropped -5.78% or -1.26 to $20.54. It is near to 17337 shares traded, which is 139.79% compare to the average total volume 12402. The market cap of CNCR is $46.22 million. The year to date change is -16.73%. The 52 week price range is from $20.4 to $32.32. Price of CNCR have changed -0.59% during last week. It have changed -11.99% over last month, -12.70% over last 3 months, -17.36% over last 6 months and -13.72% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCR is 24.12. It is 17.43% above current price. The 200-day Moving Averages for CNCR is 26.37. It is 28.38% above current price. The 52-week High is 32.32. It is 57.35% from the current price. The 52-week Low is 20.4. It is -0.68% from current price.
There are some statistics of CNCR. It is has market cap $46.22 million. The share outstanding is 2.25 million. The average volume is 12402. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCR is -16.75%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCR is -19.40%.